894 related articles for article (PubMed ID: 27016012)
1. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
2. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
[TBL] [Abstract][Full Text] [Related]
3. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
4. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
[TBL] [Abstract][Full Text] [Related]
6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
[TBL] [Abstract][Full Text] [Related]
9. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of HPV in head and neck squamous cell carcinoma.
Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
[TBL] [Abstract][Full Text] [Related]
12. The role of human papillomavirus in p16-positive oral cancers.
Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
[TBL] [Abstract][Full Text] [Related]
13. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
14. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
15. The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block.
Wilson BL; Israel AK; Lott Limbach AA
J Am Soc Cytopathol; 2021; 10(2):225-230. PubMed ID: 33092993
[TBL] [Abstract][Full Text] [Related]
16. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
Jordan RC; Lingen MW; Perez-Ordonez B; He X; Pickard R; Koluder M; Jiang B; Wakely P; Xiao W; Gillison ML
Am J Surg Pathol; 2012 Jul; 36(7):945-54. PubMed ID: 22743284
[TBL] [Abstract][Full Text] [Related]
17. Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.
Morbini P; Alberizzi P; Tinelli C; Paglino C; Bertino G; Comoli P; Pedrazzoli P; Benazzo M
Hum Pathol; 2015 May; 46(5):681-9. PubMed ID: 25708613
[TBL] [Abstract][Full Text] [Related]
18. In situ hybridization detection methods for HPV16 E6/E7 mRNA in identifying transcriptionally active HPV infection of oropharyngeal carcinoma: an updating.
Volpi CC; Ciniselli CM; Gualeni AV; Plebani M; Alfieri S; Verderio P; Locati L; Perrone F; Quattrone P; Carbone A; Pilotti S; Gloghini A
Hum Pathol; 2018 Apr; 74():32-42. PubMed ID: 28993274
[TBL] [Abstract][Full Text] [Related]
19. In situ hybridization for high risk HPV E6/E7 mRNA in oropharyngeal squamous cell carcinoma.
Suresh K; Shah PV; Coates S; Alexiev BA; Samant S
Am J Otolaryngol; 2021; 42(1):102782. PubMed ID: 33171410
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]